The Defense Logistics Agency (DLA) awarded a $5,717.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a broader Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The delivery order has an ultimate completion date of January 14, 2025. This contract award does not have a set-aside designation.
Generated 3/21/25, 9:56 AM